SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:research.chalmers.se:d041bd0b-8270-474a-844f-e2082b95f084"
 

Sökning: onr:"swepub:oai:research.chalmers.se:d041bd0b-8270-474a-844f-e2082b95f084" > Six-week follow-up ...

Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy

Gaines, Hans (författare)
Karolinska Institutet,Public Health Agency of Sweden, Solna, Sweden; Dept Med, Infect Dis Unit, Karolinska Institute, Stockholm, Sweden; Dept Infect Dis, Karolinska Univ Hosp, Stockholm, Sweden
Albert, Jan (författare)
Karolinska Institutet,Swedish Reference Group for Antiviral Therapy,Karolinska University Hospital,Dept Microbiol Tumor & Cell Biol, Karolinska Institute, Stockholm, Sweden; Dept Clin Microbiol, Karolinska Univ Hosp, Stockholm, Sweden; Swedish Reference Grp Antiviral Therapy, Stockholm, Sweden
Axelsson, Maria (författare)
Folkhälsomyndigheten,Public Health Agency of Sweden,Public Health Agency of Sweden, Solna, Sweden
visa fler...
Berglund, Torsten (författare)
Karolinska Institutet
Gisslén, Magnus, 1962 (författare)
Gothenburg University,Göteborgs universitet,University of Gothenburg,Swedish Reference Group for Antiviral Therapy,Institutionen för biomedicin, avdelningen för infektionssjukdomar,Institute of Biomedicine, Department of Infectious Medicine,Swedish Reference Grp Antiviral Therapy, Stockholm, Sweden; Dept Infect Dis, Sahlgrenska Acad, Univ Gothenburg, Gothenburg, Sweden
Sonnerborg, A. (författare)
Karolinska Institutet,Swedish Reference Group for Antiviral Therapy,Karolinska University Hospital,Dept Infect Dis, Karolinska Univ Hosp, Stockholm, Sweden; Dept Clin Microbiol, Karolinska Univ Hosp, Stockholm, Sweden; Swedish Reference Grp Antiviral Therapy, Stockholm, Sweden; Div Clin Microbiol, Dept Lab Med, Karolinska Institute, Stockholm, Sweden
Blaxhult, Anders (författare)
Karolinska Institutet
Bogdanovic, Gordana (författare)
Karolinska universitetssjukhuset,Karolinska University Hospital,Dept Clin Microbiol, Karolinska Univ Hosp, Stockholm, Sweden
Brytting, Maria (författare)
Folkhälsomyndigheten,Public Health Agency of Sweden,Public Health Agency of Sweden, Solna, Sweden
Carlander, Christina (författare)
Karolinska Institutet
Flamholc, Leo (författare)
Lund University,Lunds universitet,Enheten för infektionssjukdomar,Forskargrupper vid Lunds universitet,Infectious Diseases Research Unit,Lund University Research Groups,Swedish Reference Group for Antiviral Therapy,Swedish Reference Grp Antiviral Therapy, Stockholm, Sweden; Dept Infect Dis, Skåne Univ Hosp, Lund Univ, Malmö, Sweden
Follin, Per (författare)
Västra Götalandsregionen,Region Västra Götaland,The County of Västra Götaland,Dept Communicable Dis Control & Prevent, Region Västra Götaland, Gothenburg, Sweden
Haggar, Axana (författare)
Socialstyrelsen,National Board of Health and Welfare,Socialstyrelsen / Swedish National Board of Health and Welfare,Natl Board Hlth & Welf, Stockholm, Sweden
Hagstam, Per (författare)
Lund University,Lunds universitet,Infektionsmedicin,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Infection Medicine (BMC),Section III,Department of Clinical Sciences, Lund,Faculty of Medicine,Dept Communicable Dis Control & Prevent, Malmö, Sweden
Johansson, Marcus, 1975 (författare)
Kalmar County Hospital,Dept Clin Microbiol & Infect Dis, Kalmar Cty Hosp, Kalmar, Sweden
Navér, Lars (författare)
Karolinska Institutet,Karolinska University Hospital,Swedish Reference Group for Antiviral Therapy,Swedish Reference Grp Antiviral Therapy, Stockholm, Sweden; Dept Pediat, Karolinska Univ Hosp, Stockholm, Sweden; Dept Clin Sci Intervent & Technol, Karolinska Institute, Stockholm, Sweden
Persson Blom, Jenny (författare)
Swedish Reference Group for Antiviral Therapy,Swedish Work Environment Authority, Stockholm, Sweden
Samuelson, Agneta (författare)
Karolinska Institutet
Ström, Helena, 1985 (författare)
Socialstyrelsen,National Board of Health and Welfare,Socialstyrelsen / Swedish National Board of Health and Welfare,Natl Board Hlth & Welf, Stockholm, Sweden
Sundqvist, Martin (författare)
Region Örebro län,Clin Microbiol, Örebro University Hospital, Örebro, Sweden
Svedhem Johansson, Veronica (författare)
Karolinska Institutet
Tegmark Wisell, Karin (författare)
Karolinska Institutet,Public Health Agency of Sweden, Solna, Sweden
Tegnell, Anders (författare)
Karolinska Institutet,Public Health Agency of Sweden, Solna, Sweden
Thorstensson, Rigmor (författare)
Karolinska Institutet,Public Health Agency of Sweden, Solna, Sweden
visa färre...
 (creator_code:org_t)
2015-09-28
2016
Engelska.
Ingår i: Infectious Diseases. - : Informa UK Limited. - 2374-4235 .- 2374-4243. ; 48:2, s. 93-98
Relaterad länk:
http://dx.doi.org/10...
visa fler...
http://www.ncbi.nlm....
https://research.cha...
https://doi.org/10.3...
https://lup.lub.lu.s...
https://gup.ub.gu.se...
https://urn.kb.se/re...
http://kipublication...
visa färre...
  • Forskningsöversikt (refereegranskat)
Abstract Ämnesord
Stäng  
  • In 2014 the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy (RAV) conducted a review and analysis of the state of knowledge on the duration of follow-up after exposure to human immunodeficiency virus (HIV). Up until then a follow-up of 12 weeks after exposure had been recommended, but improved tests and new information on early diagnosis motivated a re-evaluation of the national recommendations by experts representing infectious diseases and microbiology, county medical officers, the RAV, the Public Health Agency, and other national authorities. Based on the current state of knowledge the Public Health Agency of Sweden and the RAV recommend, starting in April 2015, a follow-up period of 6 weeks after possible HIV-1 exposure, if HIV testing is performed using laboratory-based combination tests detecting both HIV antibody and antigen. If point-of-care rapid HIV tests are used, a follow-up period of 8 weeks is recommended, because currently available rapid tests have insufficient sensitivity for detection of HIV-1 antigen. A follow-up period of 12 weeks is recommended after a possible exposure for HIV-2, since presently used assays do not include HIV-2 antigens and only limited information is available on the development of HIV antibodies during early HIV-2 infection. If pre- or post-exposure prophylaxis is administered, the follow-up period is recommended to begin after completion of prophylaxis. Even if infection cannot be reliably excluded before the end of the recommended follow-up period, HIV testing should be performed at first contact for persons who seek such testing.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Infectious Medicine (hsv//eng)

Nyckelord

hiv follow-up window period
prophylaxis
hiv-2
hiv-1

Publikations- och innehållstyp

for (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy